Eurocine Vaccines is a pharmaceutical company. The company develops vaccines using its proprietary technology platform Endocine™, which vaccines are subsequently licensed to partners for further development and commercialization. Development is carried out in cooperation with other companies in the industry. The technology platform Endocine™ is also offered to other companies for development within certain indications. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.03
%
-0,40%
Latest
7.39
High
7.79
Low
7.39
Volume
12 477
Turnover (SEK)
92 803
Value (MSEK)
58,3

Board

CEO

  • Hans Arwidsson

Chairman Of The Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 5,34 5,34 2020-12-31
Jan Kennet Karjalainen 2,39 2,39 2020-12-31
Nordnet Pensionsförsäkring 2,32 2,32 2020-12-31
VisMederi Srl 1,73 1,73 2021-01-08
BRL Invest AB 1,59 1,59 2020-12-31
Niclas Falk 1,14 1,14 2020-12-31
Göran Erlandsson 1,13 1,13 2020-12-31
Kent Olsson 1,12 1,12 2020-12-31
Ari Korpela 0,83 0,83 2020-12-31
Sveinbjörn Kjartansson 0,81 0,81 2020-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream